Related Experiment Video
Updated: Jan 7, 2026

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
Proliferative Diabetic Retinopathy in Young-Onset Type 1 Diabetes in Croatia: Risk Factors and a Predictive Economic
Ivan Borjan1,2, Ivna Pleština-Borjan2, Ljubo Znaor1,2
1Department of Ophthalmology, University Hospital Split, Spinciceva 1, 21000 Split, Croatia.
Regular eye exams and strict glycemic control are crucial for preventing proliferative diabetic retinopathy (PDR) in young-onset type 1 diabetes (T1D). A national screening program is cost-effective, potentially saving millions and preventing thousands of PDR cases annually.
Area of Science:
- Ophthalmology
- Endocrinology
- Health Economics
Background:
- Proliferative diabetic retinopathy (PDR) is a significant complication of type 1 diabetes (T1D).
- Limited statistical data exists on PDR risk factors in young-onset T1D in Croatia.
- The clinical and financial impact of national diabetic retinopathy (DR) screening requires evaluation.
Purpose of the Study:
- To identify statistical risk factors for PDR in young-onset T1D patients in Croatia.
- To develop a predictive health economic model for national DR screening.
- To assess the cost-effectiveness of implementing a national DR screening program.
Main Methods:
- A cross-sectional study analyzed 58 young-onset T1D patients (June 2020-June 2022).
- Patients were classified into PDR and non-PDR groups based on fundus exams and photos.
- Logistic regression analyzed clinical, demographic, and laboratory data; a health economic model was developed.
Main Results:
- PDR was present in 47% of patients.
- PDR risk factors included longer diabetes duration, poor glycemic control, onset before 18, and irregular eye exams (OR 30-fold).
- Annual screening (60% uptake) could prevent 1973 PDR cases and save €14.2 million per 10,000 patients.
Conclusions:
- Strict glycemic control and regular eye examinations are critical for PDR prevention in young T1D.
- Establishing a national DR screening program is cost-effective, particularly in resource-limited settings.
- Screening demonstrates cost-effectiveness even with moderate uptake or less frequent intervals.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Preventive Healthcare Services

